At Novo Nordisk Capital Markets Day, Co U.S. Head Says Novo Has Gained Roughly 8 Share Points In Obesity Since January; 50% Of Entire Wegovy Franchise And 90% Of Wegovy Pill U.S. Sales Now In Self-Pay Channel

At Novo Nordisk's Capital Markets Day, the U.S. Head announced that the company has gained approximately 8 share points in the obesity market since January. Currently, 50% of the entire Wegovy franchise and 90% of Wegovy pill sales in the U.S. are now in the self-pay channel.